# RELUGOLIX
> **ANDA219913** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2026-09-02
## Drug
- **FDA Application Number:** ANDA219913
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RELUGOLIX
- **Generic name:** Relugolix
- **Active ingredients:** RELUGOLIX
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SANDOZ INC
- **First approval:** 2026-09-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219913)
---
*MORVS · CC0 1.0*